Stay updated on Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial

Sign up to get notified when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The two screenshots show the same Study Details page (NCT01627249) with no noticeable changes to content or layout.
    Difference
    0.2%
    Check dated 2025-10-27T20:55:36.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Added a prominent operating-status notice and a v3.2.0 version tag, replacing the prior v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-06T07:58:55.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0; no substantive changes to content or important data.
    Difference
    0.0%
    Check dated 2025-09-29T04:40:09.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2, and the Back to Top link has been removed.
    Difference
    0.1%
    Check dated 2025-09-14T21:55:56.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-09-07T19:10:32.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, including specific addresses in St. Louis and The Bronx, while also adding a new meta-analysis reference related to diabetic retinopathy treatment. The previous version's location and drug information have been removed.
    Difference
    4%
    Check dated 2025-08-31T12:28:14.000Z thumbnail image

Stay in the know with updates to Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aflibercept vs Bevacizumab vs Ranibizumab for DME Clinical Trial page.